| Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer | iScience |  | | 2026 | 8 | 4 |
|
| Actionable mutations in pancreatic cancer : where targeted therapies are making a difference | BMJ open gastroenterology | | | 2025 | 13 | 173 |
|
| Impact of Neoadjuvant Immunotherapy in Localized Rectal Cancer. A Systematic Review | Clinical colorectal cancer | | | 2025 | 25 | 409 |
|
| Narrative Review : Predictive Biomarkers of Tumor Response to Neoadjuvant Radiotherapy or Total Neoadjuvant Therapy of Locally Advanced Rectal Cancer Patients | Cancers | | | 2025 | 43 | 250 |
|
| Prise en charge du cancer du rectum localisé en 2024 | Revue médicale suisse | | | 2024 | 157 | 27 |
|
| Promises and challenges of predictive blood biomarkers for locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy | Cells | | | 2023 | 127 | 367 |
|
| Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer | BMC cancer | | | 2022 | 267 | 290 |
|
| The first comprehensive genomic characterization of rectal squamous cell carcinoma | Journal of gastroenterology | | | 2022 | 195 | 307 |
|
| Emerging Trends for Radio-Immunotherapy in Rectal Cancer | Cancers | | | 2021 | 65 | 211 |
|
| Debating Pros and Cons of Total Neoadjuvant Therapy in Rectal Cancer | Cancers | | | 2021 | 112 | 1,638 |
|
